Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Jacobs

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Applied Toxicology : JAT|January 25, 2018
Integrated decision strategies for skin sensitization hazardJudy Strickland, Qingda Zang, Nicole Kleinstreuer, et al.
Critical Reviews in Toxicology|May 17, 2017
Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluationAlan Boobis, Paul Brown, Mark Timothy David Cronin, et al.
Regulatory Toxicology and Pharmacology : RTP|November 9, 2017
Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of actionSusan P Felter, Jennifer E Foreman, Alan Boobis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 6, 2003
The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESIJames MacDonald, John E French, Ronald J Gerson, et al.
ALTEX|July 26, 2014
Developing microphysiological systems for use as regulatory tools--challenges and opportunitiesMelvin E Andersen, Kellyn Betts, Yvonne Dragan, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agenciesJudy Strickland, Amy J Clippinger, Jeffrey Brown, et al.
Regulatory Toxicology and Pharmacology : RTP|April 15, 2019
Analysis of exposure margins in developmental toxicity studies for detection of human teratogensPaul A Andrews, Diann Blanset, Priscila Lemos Costa, et al.
Archives of Toxicology|November 1, 2018
Skin sensitization testing needs and data uses by US regulatory and research agenciesJudy Strickland, Amber B Daniel, David Allen, et al.
Archives of Toxicology|June 29, 2020
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogensMiriam N Jacobs, Annamaria Colacci, Raffaella Corvi, et al.
The AAPS Journal|March 21, 2013
CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug productsCelia N Cruz, Katherine M Tyner, Lydia Velazquez, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Applied Toxicology : JAT|January 25, 2018
Integrated decision strategies for skin sensitization hazardJudy Strickland, Qingda Zang, Nicole Kleinstreuer, et al.
Critical Reviews in Toxicology|May 17, 2017
Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluationAlan Boobis, Paul Brown, Mark Timothy David Cronin, et al.
Regulatory Toxicology and Pharmacology : RTP|November 9, 2017
Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of actionSusan P Felter, Jennifer E Foreman, Alan Boobis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 6, 2003
The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESIJames MacDonald, John E French, Ronald J Gerson, et al.
ALTEX|July 26, 2014
Developing microphysiological systems for use as regulatory tools--challenges and opportunitiesMelvin E Andersen, Kellyn Betts, Yvonne Dragan, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agenciesJudy Strickland, Amy J Clippinger, Jeffrey Brown, et al.
Regulatory Toxicology and Pharmacology : RTP|April 15, 2019
Analysis of exposure margins in developmental toxicity studies for detection of human teratogensPaul A Andrews, Diann Blanset, Priscila Lemos Costa, et al.
Archives of Toxicology|November 1, 2018
Skin sensitization testing needs and data uses by US regulatory and research agenciesJudy Strickland, Amber B Daniel, David Allen, et al.
Archives of Toxicology|June 29, 2020
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogensMiriam N Jacobs, Annamaria Colacci, Raffaella Corvi, et al.
The AAPS Journal|March 21, 2013
CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug productsCelia N Cruz, Katherine M Tyner, Lydia Velazquez, et al.
Pageof 4